[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100554377":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":35,"collaborators":7,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":39,"sex":45,"minAge":46,"maxAge":7,"enrollmentInfo":47,"targetDuration":7,"studyType":50,"phases":7,"briefSummary":51,"conditions":52,"keywords":54,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"University Hospital, Strasbourg, France","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Alexandre BOUSSUGE, MD","CONTACT","33 3 88 11 54 61","alexandre.boussuge@chru-strasbourg.fr",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Service de Soins de Soins Médicaux et de Réadaptation - CHU de Strasbourg - France","RECRUITING","Strasbourg","67091","France","FR",{"type":23,"coordinates":24},"Point",[25,26],7.74553,48.58392,{"lat":26,"lon":25},[29,30,32],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"name":10,"role":31,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"name":33,"role":34,"phone":7,"phoneExt":7,"email":7},"Marie LEVEQUE, MD","SUB_INVESTIGATOR",{"type":36,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100554377","analysis-of-the-impact-of-a-temporo-spatial-reorientation-tool-on-the-speed-of-improvement-of-confusional-syndrome-100554377",false,"NCT06498297","Analysis of the Impact of a Temporo-spatial Reorientation Tool on the Speed of Improvement of Confusional Syndrome","Analysis of the Impact of a Temporo-spatial Reorientation Tool on the Speed of Improvement of Confusional Syndrome, Assessed by the 4 \"A\" Test, in Patients Aged Over 75 Years Hospitalized in the Medical and Health Care Department. Geriatric Rehabilitation.","Rob'Gazette","Inclusion Criteria:\n\n* Patient aged 75 and over\n* Hospitalized at the HUS in the SMRG department during the period from January 1, 2021 to April 31, 2023\n* Passed at least a 4AT during hospitalization\n* Absence of written opposition in the patient's medical file (and\u002For their legal representative if applicable) to the reuse of their data for scientific research purposes.\n\nExclusion Criteria:\n\n\\- Presence of written opposition from the patient (and\u002For their legal representative if applicable) in their medical file.","ALL","75 Years",{"count":48,"type":49},500,"ESTIMATED","OBSERVATIONAL","Confusion syndrome is defined by attentional disorders and disorganization of cognitive functions that are acute and reversible. There are patient-specific predisposing factors and precipitating factors. Elderly people, due to their comorbidities, are more at risk. Confusion syndrome affects approximately 23% of elderly patients in the medical department, 33% in the rehabilitation department and its occurrence is preventable in 30 to 40% of cases. The health expenditure generated by its occurrence was estimated at 182 billion dollars per year by combining the expenditure of 18 European countries in 2011. The occurrence of a delirium increases the duration of hospitalization, increases the risk of falls, loss of autonomy, can lead to an impairment of quality of life at 6 months and is linked to excess mortality.\n\nThe gold standard for making the diagnosis of delirium is the use of the DSM-5 criteria, but their use is time-consuming and requires that staff be trained in their use. The 4 \"A\" test (tool to help identify confusional syndrome) can be used to monitor confusional syndromes; it has the advantage of being able to be taken in less than 3 minutes.\n\nConcerning the management of a confusional syndrome, a non-pharmacological multi-component approach is recommended as first line for its prevention but there is no treatment to date. A tool to help with temporo-spatial reorientation (La Rob'Gazette) has been set up in the Medical Care and Geriatric Rehabilitation (SMRG) departments of the HUS",[53],"Attention Disorder",[53,55,56,57],"Confusion syndrome","Attentional disorders","Disorganization of cognitive functions","2024-07-04",{"date":60,"type":61},"2024-07-12","ACTUAL",{"date":63,"type":61},"2023-10-24",{"date":65,"type":49},"2025-04-24",{"name":5,"class":6},1]